Ralph Zitnik, MD

Ralph attended Rush Medical College and got his training in internal medicine and pulmonary and critical care medicine at Yale where he was on the Faculty in the Pulmonary Medicine Division. He moved into industry 30 years ago and had positions of increasing responsibility at Bayer, Pfizer, Immunex and Amgen where his focus included Asthma and COPD clinical studies. While at Amgen he was global development leader for Enbrel and Prolia. He was the founding CMO at SetPoint Medical, a company that developed a neuroimmune modulation device for rheumatoid arthritis.